Novo Nordisk Aktie
50,79
EUR
+0,51
EUR
+1,01
%
46,29
CHF
+2,78
CHF
+6,39
%
Werbung
Novo Nordisk Aktie Analyse
04.08.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
04.08.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
29.07.21 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
19.07.21 | Novo Nordisk Overweight | Barclays Capital | |
12.07.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
07.07.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
30.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
28.06.21 | Novo Nordisk Neutral | UBS AG | |
Werbung
|
|||
28.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
24.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
24.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.06.21 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
10.06.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.06.21 | Novo Nordisk Outperform | Bernstein Research | |
10.06.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.06.21 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
01.06.21 | Novo Nordisk buy | Deutsche Bank AG | |
24.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
21.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
19.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
06.05.21 | Novo Nordisk Neutral | Credit Suisse Group | |
06.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
06.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.05.21 | Novo Nordisk overweight | Barclays Capital | |
05.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
28.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
14.04.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
13.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
25.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
23.03.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
23.03.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
05.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
04.03.21 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
18.02.21 | Novo Nordisk Neutral | UBS AG | |
16.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
11.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
09.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
08.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.02.21 | Novo Nordisk overweight | Barclays Capital | |
04.02.21 | Novo Nordisk Neutral | Credit Suisse Group | |
04.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.02.21 | Novo Nordisk Outperform | Bernstein Research | |
03.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.02.21 | Novo Nordisk Neutral | UBS AG |
Werbung
Werbung